Innovative Research Identifies Rare Immune Cells as Potential Breakthrough in Treating ARDS
New research highlights the potential of basophils, a rare immune cell type, to promote recovery from acute respiratory distress syndrome through immune modulation, offering hope for innovative treatments.
Recent scientific advancements have uncovered a promising new avenue for treating acute respiratory distress syndrome (ARDS), a severe and often fatal lung condition. Researchers at the Institute of Science Tokyo have found that basophils, a relatively rare subset of white blood cells typically linked to allergic reactions, may play a crucial role in aiding recovery from ARDS. In their experimental studies using a mouse model, they observed that basophils release interleukin-4 (IL-4), a cytokine that helps suppress the inflammatory activity of neutrophils—another type of white blood cell involved in lung inflammation.
The study, published in the European Respiratory Journal, demonstrated that mice lacking basophils experienced worse lung damage, increased inflammation, and slower recovery. Conversely, when IL-4 was produced by basophils, it acted directly on neutrophils to inhibit the expression of inflammatory genes and promote cell death, leading to reduced lung inflammation and better healing.
This discovery challenges previous assumptions that viewed basophils solely as 'bad actors' in immune responses, highlighting their beneficial role during the resolution phase of ARDS. The findings suggest potential new therapies that could target the basophil–IL-4–neutrophil pathway to enhance recovery in ARDS patients. However, the researchers note that the source of IL-4 in human ARDS remains unknown, representing an important area for future investigation.
ARDS is characterized by fluid buildup in the alveoli, impairing oxygen exchange and often resulting from severe infections like pneumonia, COVID-19, or sepsis. Despite advances in intensive care, mortality rates remain high, and effective targeted treatments are still lacking. This groundbreaking research opens the door for developing therapies that harness the immune-modulating capabilities of basophils to improve patient outcomes.
Source: https://medicalxpress.com/news/2025-09-rare-immune-cells-acute-respiratory.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Effective School-Based Dental Treatments Halt Childhood Tooth Decay
School-based dental treatments like ART and SDF have proven highly effective in preventing and controlling childhood tooth decay, offering a non-invasive solution to improve children's oral health.
Global Estimates Highlight the Impact of Inadequate Type 1 Diabetes Care on Mortality and Population Loss
Recent research reveals that over 4 million lives could be saved in 2025 with better type 1 diabetes care, emphasizing urgent global health disparities and the need for improved access to treatment.
Protecting Healthcare Workers Amid Rising Measles Cases: The Importance of Vaccination
As measles cases surge globally, protecting healthcare workers through vaccination is vital to prevent transmission and safeguard vulnerable populations. Learn how education and improved screening can boost vaccination rates among health professionals.
Why Getting Your Flu Vaccine This Season Is Essential and Who Should Get It
Learn why getting a flu shot this season is crucial for all eligible individuals, especially vulnerable groups, to prevent severe illness and complications. October is the optimal time to vaccinate.